Request a representative visit or G7 15 Day or G7 samples
Resources
The efficacy and safety of the Control-IQ hybrid closed-loop system, powered by Dexcom G6, was evaluated in a multi-centered, randomized, and unblinded study. 1 The researchers randomized 168...
The Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study, published in the Journal of American Medical Association in 2020, 1 was one of the first randomized control continuous glucose...
A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group Petrie J, et al. Improving the Clinical Value and...
Exercise is vital for managing type 1 diabetes, but it can disrupt glucose levels, leading to fears of hypoglycemia. Utilizing intermittently scanned CGM (isCGM) and continuous glucose monitoring (CGM...
Do your patients ask you about their sensor staying on, have sensitive skin, or find it hard to remove the sensor adhesive? These resources may help.
The Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available to more of your eligible Medicare patients with Type 1 or Type 2 diabetes. In order for patients to qualify for Medicare...
